Regulus Therap (RGLS) Reports Q4 Loss of 22c
Tweet Send to a Friend
Regulus Therap (NASDAQ: RGLS) reported Q4 EPS of ($0.22). May ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
